Recent Quotes (30 days)

You have no recent quotes
chg | %

Angiotech Pharmaceuticals, Inc.  

(Public, TSE:ANP)   Watch this stock  
Find more results for ANP
1.13
Apr 9 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.55 - 3.10
Open     -
Vol / Avg. 0.00/115,000.00
Mkt cap 96.23M
P/E     -
Div/yield     -
EPS -0.27
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '11) 2010
Net profit margin 653.56% -27.13%
Operating margin 661.96% -11.79%
EBITD margin - 8.88%
Return on average assets 322.70% -19.76%
Return on average equity - -
CDP Score - -

Address

1618 Station Street
VANCOUVER, BC V6A 1B6
Canada
+1-604-2217676 (Phone)
+1-604-2212330 (Fax)

Website links

Description

Angiotech Pharmaceuticals, Inc. (Angiotech) is a Canada-based global medical device company. The Company develops and markets technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. Angiotech has a subsidiary, Surgical Specialties Corporation (Surgical Specialties), which develops and manufactures surgical instruments for its own brands (Quill knotless tissue closure device, SSC Surgical Suture, Look brand sutures, Sharpoint / SSC Microsurgical Knives, BioSentry). Surgical Specialties is an original equipment manufacturer for medical device companies in the United States and other parts in the world. It has partnerships within dental, ophthalmic, plastic surgery, dermatology, orthopedics, urology, microsurgery, veterinary and trauma specialties areas. Surgical Specialties provides customized surgical device solutions.